Abnormal Liver Biopsies of Donor Grafts in Pediatric Liver Transplantation: How Do They Fare?

Jason Guo; Jorge A. Sanchez-Vivaldi; Madhukar S. Patel; Benjamin K. Wang; Andrew D. Shubin; Yash Kadakia; Jigesh A. Shah; Malcolm MacConmara; Steven Hanish; Parsia A. Vagefi; Christine S. Hwang

doi:10.12659/AOT.944245

06 August 2024 : Original article

Abnormal Liver Biopsies of Donor Grafts in Pediatric Liver Transplantation: How Do They Fare?

Jason Guo

^1ABCDEF, Jorge A. Sanchez-Vivaldi^23ABCDEF, Madhukar S. Patel^23ADE, Benjamin K. Wang^1ABC, Andrew D. Shubin^23ABCD, Yash Kadakia^1E, Jigesh A. Shah^23E, Malcolm MacConmara

^234DEF, Steven Hanish^23E, Parsia A. Vagefi^23E, Christine S. Hwang^23ACDEF*

DOI: 10.12659/AOT.944245

Ann Transplant 2024; 29:e944245

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 3 Survival analysis of abnormal livers by each abnormal factor, including >5% macrosteatosis (A), fibrosis (B), and inflammation (C). Normal liver (NL) survival is shown in green as a comparison. Graft survival was defined as time from transplant to graft failure. Log-rank tests for statistical significance was performed comparing each factor to NL. Figure generated using GraphPad Prism (v10.2.2, GraphPad Software, Boston, MA)

Back to the Article

Abnormal Liver Biopsies of Donor Grafts in Pediatric Liver Transplantation: How Do They Fare?

Your Privacy